SynthesisESMO open2022

Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis.

B A Maiorano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.